Biotech Values

[DewDiligence]

Sanofi Reports 4Q08 Annualized Lovenox Sales of $3.8B

[The sales figures are in Euros, Sanofi’s reporting currency, and the growth rates are in constant local currencies, which is a way to track the growth in volume and price irrespective of currency swings. (Sanofi does not report quarter-over-quarter growth in local currencies, and hence meaningful quarter-over-quarter numbers are hard to come by.) Note: the sales figures below are annualized, i.e. they are 4x the 4Q08 numbers. ]


Worldwide Lovenox sales rose 8% year-over-year to an annualized rate of €3.0B, which is $3.8B at the current exchange rate. The breakdown by geography is as follows:

US: €1.79B (60% of total), +7 YoY,
EU: €884M (30% of total), +11% YoY
RoW: €324M (11% of total), +8% YoY
===
Total: €3.00B, +8% YoY

Source:
http://en.sanofi-aventis.com/binaries/20081031_Results2008_Q3_slides_tcm28-22500.pdf